home All News open_in_new Full Article

Alzheimer : polémique autour du Leqembi, un médicament à quelques milliards d’euros

L'ENQUETE DU DIMANCHE. Entre lobbying pharmaceutique et detresse des familles, la France hesite a rembourser ce medicament au cout exorbitant, aux benefices tres limites et pas sans risques.


today 9 h. ago attach_file Economics

attach_file Science
attach_file Science
attach_file Economics
attach_file Science
attach_file Science
attach_file Transport
attach_file Transport
attach_file Economics
attach_file Politics
attach_file Events
attach_file Politics
attach_file Science
attach_file Events
attach_file Society
attach_file Science
attach_file Science
attach_file Science
attach_file Science
attach_file Politics
attach_file Society


ID: 3786659210
Add Watch Country

arrow_drop_down